
Matrixome is a Japanese-based company behind the original creator of the laminin E8 fragment substrate and the gold standard for iPSC generation and maintenance pioneered by Professor Sekiguchi out of Osaka University. Already employed in numerous global clinical trials and studies and trusted by large therapeutic and pharmaceutical companies around the world, the iMatrix product line, with the clinical versions approved by the PMDA, is one you trust in your clinical trials and research. Visit our booth for an exciting new product launch that will change the world of stem cells and differentiation forever!
Matrixome
3-2 Yamadaoka
Suita
565-0871
Japan